Dongming Wu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Inflammasome and immune disorders
- Advanced biosensing and bioanalysis techniques
- Extracellular vesicles in disease
Papers in
-
- Inflammasome and immune disorders 20
- RNA modifications and cancer 10
- Circular RNAs in diseases 5
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 8
- Co-authors
- Ying Xu (42 shared papers)Shihua Deng (33 shared papers)Teng Liu (20 shared papers)Rong Han (10 shared papers)Li Li (4 shared papers)Ye Yu (8 shared papers)Jin Li (7 shared papers)Miao He (10 shared papers)
- Journals
- International Immunopharmacology (4 papers)Cell Death and Disease (4 papers)Scientific Reports (3 papers)OncoTargets and Therapy (3 papers)Frontiers in Pharmacology (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Dongming Wu
74 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 133
- Cancer Research 491
- Molecular Biology 1.0k
- Pulmonary and Respiratory Medicine 359
- Nephrology 72
- Immunology 162
Countries citing papers authored by Dongming Wu
This map shows the geographic impact of Dongming Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongming Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongming Wu more than expected).
Fields of papers citing papers by Dongming Wu
This network shows the impact of papers produced by Dongming Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongming Wu. The network helps show where Dongming Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongming Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 112 | |
| 2 | 2015 | 107 | |
| 3 | 2021 | 102 | |
| 4 | 2018 | 94 | |
| 5 | 2021 | 83 | |
| 6 | 2019 | 79 | |
| 7 | 2020 | 75 | |
| 8 | 2021 | 68 | |
| 9 | 2016 | 57 | |
| 10 | 2014 | 57 | |
| 11 | 2023 | 53 | |
| 12 | 2020 | 51 | |
| 13 | 2022 | 47 | |
| 14 | 2019 | 45 | |
| 15 | 2001 | 41 | |
| 16 | 2018 | 40 | |
| 17 | 2022 | 37 | |
| 18 | 2022 | 33 | |
| 19 | 2017 | 32 | |
| 20 | 2017 | 29 |
About Dongming Wu
Dongming Wu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 78 papers that have together received 1.7k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (20 papers), Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (10 papers), Ferroptosis and cancer prognosis (8 papers), Effects of Radiation Exposure (8 papers), MicroRNA in disease regulation (8 papers), Obesity, Physical Activity, Diet (6 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (491 citations), Molecular Biology (1.0k citations), Pulmonary and Respiratory Medicine (359 citations), Nephrology (72 citations) and Immunology (162 citations). Dongming Wu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ying Xu, Shihua Deng, Teng Liu, Rong Han, Li Li, Ye Yu, Jin Li, Miao He, Yangyang Zhao and Ting Zhang. Their work appears in journals such as International Immunopharmacology, Cell Death and Disease, Scientific Reports, OncoTargets and Therapy and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.